BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 2/27/2013 10:17:40 AM : Outperform Start Price: $1.21 BCRX Score: +5.80

good buyin price with increasing value in its sites

Featured Broker Partners


Advertisement